REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gongwin Biopharm Holdings Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Gongwin Biopharm Holdings Co., Ltd. Profile Updated: November 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Gongwin Biopham Holdings Co., Ltd. specializes in anti-cancer drug research and development. Company's main product, PTS active ingredients of anti-cancer drugs. Gongwin Biopham was established in year 2014.

Headquarters
3F, No. 80, Sec. 1, Jianguo North Road, Zongshan Dist
Taipei City; Taipei City;

Contact Details: Purchase the Gongwin Biopharm Holdings Co., Ltd. report to view the information.

Website: http://www.gongwinbiopharm.com

Basic Information
Total Employees:
Purchase the Gongwin Biopharm Holdings Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Gongwin Biopharm Holdings Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Gongwin Biopharm Holdings Co., Ltd. report to view the information.
Incorporation Date:
March 27, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
12.99%
Purchase this report to view the information.
2.39%
Purchase this report to view the information.
1.57%
Purchase this report to view the information.
0.83%
Purchase this report to view the information.
0.53%
Subsidiaries
Pts International Inc. (United States)
100%
共信醫藥科技股份有限公司
100%
Company Performance
Financial values in the chart are available after Gongwin Biopharm Holdings Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
1113.4%▲
Total operating revenue
1288.51%▲
Operating profit (EBIT)
2.81%▲
EBITDA
-57.24%▼
Net Profit (Loss) for the Period
-10.6%▼
Total assets
126.99%▲
Total equity
144.83%▲
Operating Profit Margin (ROS)
5205.49%▲
Net Profit Margin
3826.49%▲
Return on Equity (ROE)
1.96%▲
Debt to Equity Ratio
-3.36%▼
Quick Ratio
3.99%▲
Cash Ratio
6.43%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo